<DOC>
	<DOCNO>NCT02040337</DOCNO>
	<brief_summary>The purpose study investigate CD8 + T-cell receptor ( TCR ) repertoire difference patient type 1 diabetes mellitus type 2 diabetes healthy control .</brief_summary>
	<brief_title>Sequencing T-cells Type I Diabetes Mellitus</brief_title>
	<detailed_description>Using system biology approach combine high-throughput sequencing , cytometry , gene expression , transcriptome profiling , HLA typing , single cell analysis , TCR affinity assay , investigator define set immune metric prediction early diagnosis disease superior current examination auto-antibodies , fairly late stage disease development . This also use guide therapy advance disease .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Patients must current previous diagnosis Type I Diabetes ( Autoimmunerelated T1DA confirm positive test glutamic acid decarboxylase ( GAD ) autoantibody . When available , idiopathic T1DB patient lack autoantibody GAD recruit ) Patients must ≥ 18 year old ≤55 year old Inclusion criterion : patient T2D control Patients must current previous diagnosis T2D Patients must ≥ 18 year old ≤55 year old • &lt; 18 year old ; &gt; 55 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>